These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 1990597)
1. Comparison of the immunosuppressive effects of mycophenolic acid and the morpholinoethyl ester of mycophenolic acid (RS-61443) in recipients of heart allografts. Morris RE; Wang J Transplant Proc; 1991 Feb; 23(1 Pt 1):493-6. PubMed ID: 1990597 [No Abstract] [Full Text] [Related]
2. Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts. Morris RE; Wang J; Blum JR; Flavin T; Murphy MP; Almquist SJ; Chu N; Tam YL; Kaloostian M; Allison AC Transplant Proc; 1991 Apr; 23(2 Suppl 2):19-25. PubMed ID: 2063417 [No Abstract] [Full Text] [Related]
3. Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis. Morris RE; Hoyt EG; Murphy MP; Eugui EM; Allison AC Transplant Proc; 1990 Aug; 22(4):1659-62. PubMed ID: 2389428 [No Abstract] [Full Text] [Related]
4. A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts. Nakakura EK; McCabe SM; Zheng B; Shorthouse RA; Scheiner TM; Blank G; Jardieu PM; Morris RE Transplant Proc; 1993 Feb; 25(1 Pt 1):809-12. PubMed ID: 8438493 [No Abstract] [Full Text] [Related]
5. Effect of splenectomy and mono- or combination therapy with rapamycin, the morpholinoethyl ester of mycophenolic acid and deoxyspergualin on cardiac xenograft survival. Wang J; Morris RE Transplant Proc; 1991 Feb; 23(1 Pt 1):699-702. PubMed ID: 1990655 [No Abstract] [Full Text] [Related]
6. Efficacy of rapamycin, RS-61443, and cyclophosphamide in the prolongation of survival of discordant pig-to-rabbit cardiac xenografts. Yatscoff RW; Wang S; Keenan R; Chackowsky P; Koshal A Transplant Proc; 1994 Jun; 26(3):1271-3. PubMed ID: 8029905 [No Abstract] [Full Text] [Related]
7. Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation. Tanabe M; Todo S; Murase N; Irish W; Miyazawa H; Fujisaki S; Starzl TE Transplant Proc; 1995 Feb; 27(1):364-5. PubMed ID: 7533411 [No Abstract] [Full Text] [Related]
8. Prolongation of allograft and xenograft survival with mycophenolate mofetil (RS-61443) and brequinar sodium (DUP-785). Hullett DA; Kawamura T; Fujino Y; Allison AM; Sollinger HW Transplant Proc; 1993 Feb; 25(1 Pt 1):700-1. PubMed ID: 8438444 [No Abstract] [Full Text] [Related]
9. Synergistic effects of mycophenolate mofetil (MMF, RS-61443) and anti-LFA-1/ICAM-1 monoclonal antibodies on the prolongation of heart allograft survival in rats. Takazawa K; Hosoda Y; Bashuda H; Seino K; Yagita H; Tamatani T; Miyasaka M; Okumura K Transplant Proc; 1996 Jun; 28(3):1980-1. PubMed ID: 8658967 [No Abstract] [Full Text] [Related]
10. Heterotopic rat intestinal transplantation: effect of cyclosporine and RS-61443 on graft-vs-host disease and rejection. D'Alessandro AM; Rankin MA Transplant Proc; 1994 Jun; 26(3):1611-2. PubMed ID: 8030056 [No Abstract] [Full Text] [Related]